Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dalzanemdor (SAGE-718) is an NMDA receptor-positive modulator of metabolism that can be used to study Huntington's chorea, Alzheimer's disease, and cognitive dysfunction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | Inquiry | |
5 mg | In stock | $ 1,470.00 | |
25 mg | 8-10 weeks | Inquiry | |
50 mg | 8-10 weeks | Inquiry |
Description | Dalzanemdor (SAGE-718) is an NMDA receptor-positive modulator of metabolism that can be used to study Huntington's chorea, Alzheimer's disease, and cognitive dysfunction. |
In vivo | SAGE-718 (Dalzanemdor) (5), a potent and high intrinsic activity NMDAR PAM with an optimized pharmacokinetic profile for oral dosing. Compound 5 has completed phase 1 single ascending dose and multiple ascending dose clinical trials and is currently undergoing phase 2 clinical trials for the treatment of cognitive impairment in Huntington's disease.[2] |
Synonyms | SAGE-718 |
Molecular Weight | 456.62 |
Formula | C27H43F3O2 |
CAS No. | 1629853-48-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
chloroform: 5.68mg/mL (12.44mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dalzanemdor 1629853-48-0 Membrane transporter/Ion channel Neuroscience NMDAR iGluR SAGE-718 SAGE718 SAGE 718 inhibitor inhibit